[1-(1-methyl-1H-pyrazol-4-yl)cyclopropyl]amine dihydrochloride, 95.0%, 500mg

tert-Butyl (1-(6-bromopyridin-2-yl)cyclobutyl)carbamate, 95.0%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-phenylacetic acid, 95.0%, 1g

(4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, 97%, 10g

(S)-N-((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide, 95.0%, 1g

Fmoc-D-Asp-OH, 95.0%, 25g

TRANS-TERT-BUTYL 4-HYDROXY-3-PHENYLPIPERIDINE-1-CARBOXYLATE, 95.0%, 250mg

tert-Butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate, 95.0%, 1g

Dysprosium oxide powder 99+% 25 g

Ethyl 3-(5-methylfuran-2-yl)-3-oxopropanoate, 98%, 100mg

(3,5-Dibromo-4-butoxyphenyl)methanol, 98%, 500mg

7-bromo-5-fluoro-1,4-dihydroquinazolin-4-one, 98%, 1g

Methyl 4-morpholinecarbodithioate, 95+%, 1g